These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32410504)

  • 1. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.
    Khan MT; Ali A; Wang Q; Irfan M; Khan A; Zeb MT; Zhang YJ; Chinnasamy S; Wei DQ
    J Biomol Struct Dyn; 2021 Jul; 39(10):3627-3637. PubMed ID: 32410504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape.
    Rampogu S; Gajula RG; Lee G; Kim MO; Lee KW
    Comput Biol Med; 2021 Aug; 135():104525. PubMed ID: 34252682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition.
    Gaudêncio SP; Pereira F
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33322052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study.
    Khan MT; Ali A; Wei X; Nadeem T; Muhammad S; Al-Sehemi AG; Wei D
    Braz J Biol; 2022; 84():e250667. PubMed ID: 35475989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach.
    Bhowmick S; Saha A; Osman SM; Alasmary FA; Almutairi TM; Islam MA
    Mol Divers; 2021 Aug; 25(3):1979-1997. PubMed ID: 33844135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies.
    Halimi M; Bararpour P
    J Mol Model; 2022 Aug; 28(9):279. PubMed ID: 36031629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
    Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational screening for potential drug candidates against the SARS-CoV-2 main protease.
    Silva Andrade B; Ghosh P; Barh D; Tiwari S; José Santana Silva R; Rodrigues de Assis Soares W; Silva Melo T; Santos Freitas A; González-Grande P; Sousa Palmeira L; Carlos Junior Alcantara L; Giovanetti M; Góes-Neto A; Ariston de Carvalho Azevedo V
    F1000Res; 2020; 9():. PubMed ID: 33447372
    [No Abstract]   [Full Text] [Related]  

  • 10. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.
    Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B
    Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
    Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
    Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against M
    Mejías FJR; Durán AG; Chinchilla N; Varela RM; Álvarez JA; Molinillo JMG; García-Cozar F; Macías FA
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M
    J A; Francis D; C S S; K G A; C S; Variyar EJ
    J Biomol Struct Dyn; 2022 Jan; 40(1):325-336. PubMed ID: 32873185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (M
    Elgohary AM; Elfiky AA; Pereira F; Abd El-Aziz TM; Sobeh M; Arafa RK; El-Demerdash A
    Comput Biol Med; 2022 Aug; 147():105738. PubMed ID: 35777088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
    Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
    Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ramadhan DSF; Siharis F; Abdurrahman S; Isrul M; Fakih TM
    J Biomol Struct Dyn; 2022; 40(22):11526-11532. PubMed ID: 34338602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M
    Potshangbam AM; Nongdam P; Kumar AK; Rathore RS
    Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
    Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
    Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.